MedPath

Effect of Kautajadi Sheelajatu and Punarnava Mandoor in Pandu

Phase 2
Conditions
Health Condition 1: D509- Iron deficiency anemia, unspecified
Registration Number
CTRI/2024/04/066289
Lead Sponsor
Dr Meenakshi Thakur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients having symptoms (Panduta, Daurbalya, Aarohanaayas Vishesh Shwas (Dyspnoea), Pindikodweshtan, Sadana (Fatigue), Gaurav) of Pandu

2) Patients having Hb%

For Female: 8- 11.9 gm%

For Male: 8-12.9 gm%

3) Patient who are ready to give written consent will be included.

Exclusion Criteria

1) Patients having symptoms of Pandu roga but suffering any other chronic diseases like diabetes mellitus and hypertension, subjects with abnormal hemopoiesis like megaloblastic Anaemia, unusual haemolysis due to red cell membrane defects, hereditary spherocytosis, hereditary elliptocytosis, and malaria, auto immune haemolytic Anaemia, unusual blood loss like gastro intestinal bleeding, physical trauma, haemoglobinopathies like sickle cell Anaemia, leukemia, thalassaemia and patients with infectious diseases will be excluded.

2) Pregnant women and lactating mothers.

3) Patients who are not ready to give written consent will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in Panduta present in Nakha, Netra, Jivha and Hastapadtal after 90 days. <br/ ><br>Timepoint: Baseline, 30 days, 60 days, 90 days <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Relief in Panduta present in Nakha, Netra, Jivha & Hastapadtal 30 days, 60 daysTimepoint: Baseline, 30 days, 60 days, 90 days
© Copyright 2025. All Rights Reserved by MedPath